Global Adult Vaccines Market Growth, Share, Size, Trends and Forecast (2023 - 2029)
Segmented by Vaccine;
Influenza, Tetanus, Diphtheria, Pertussis (Td/Tdap), Varicella, Human Papillomavirus, Zoster, Measles, Mumps, Rubella (MMR), Pneumococcal, Hepatitis and Others.Segmented by Vaccine Type;
Monovalent and Multivalent.Segmented by technology;
Live Attenuated Vaccines, Inactivated Viral/Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines and Conjugate Vaccines.Segmented by End Use Industry;
Hospitals, Clinics and Long Term Care Facilities - Homecare and Hospice.Segmented by Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2019 - 2029).Introduction
Global Adult Vaccines Market (USD Million), 2019 - 2029
# | Global |
---|---|
2019 | 54.6 |
2020 | 62.3 |
2021 | 70.5 |
2022 | 79.4 |
2023 | 87.6 |
2024 | 100.0 |
2025 | 102.0 |
2026 | 119.6 |
2027 | 126.2 |
2028 | 137.3 |
2029 | 153.9 |
In the year 2022, the Global Adult Vaccines Market was valued at USD 4,780.98 million. The size of this market is expected to increase to USD 7,931.89 million by the year 2029, while growing at a Compounded Annual Growth Rate (CAGR) of 7.5%.
Global Adult Vaccines Market Report Snapshot
Parameters | Description |
---|---|
Market | Global Adult Vaccines Market |
Study Period | 2019 - 2029 |
Base Year (for Adult Vaccines Market Size Estimates) | 2022 |
Study Scope |
|
Market Segmentation |
|
Geographical Coverage |
|
Company Coverage |
|
Premium Insights |
|
Market Analysis
This report extensively covers different segments of Global Adult Vaccines Market and provides an in depth analysis (including revenue analysis for both historic and forecast periods) for all the market segments. In this report, the analysis for every market segment is substantiated with relevant data points and, insights that are generated from analysis of these data points (data trends and patterns).
Global Adult Vaccines Market Analysis
In this report, the Global Adult Vaccines Market has been segmented by Vaccine, Vaccine Type, technology, End Use Industry and Geography.
Global Adult Vaccines Market, Segmentation by Vaccine
The Global Adult Vaccines Market has been segmented by Vaccine into Influenza, Tetanus, Diphtheria, Pertussis (Td/Tdap), Varicella, Human Papillomavirus, Zoster, Measles, Mumps, Rubella (MMR), Pneumococcal, Hepatitis and Others. The complete Global Adult Vaccines Market segmentation by Vaccine can be seen below:
- Global Adult Vaccines Market, By Vaccine
- Influenza
- Tetanus, Diphtheria, Pertussis (Td/Tdap)
- Varicella
- Human Papillomavirus
- Zoster
- Measles, Mumps, Rubella (MMR)
- Pneumococcal
- Hepatitis
- Others
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Vaccines mentioned above for historic (2019 - 2022) and forecast (2023 - 2029) periods with 2022 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Vaccine is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Adult Vaccines Market, by Vaccine (USD Million), 2019 - 2029
# | Influenza | Tetanus, Diphtheria, Pertussis (Td/Tdap) | Varicella | Human Papillomavirus | Zoster | Measles, Mumps, Rubella (MMR) | Pneumococcal | Hepatitis | Others |
---|---|---|---|---|---|---|---|---|---|
2019 | 84.1 | 88.1 | 70.9 | 83.3 | 96.9 | 64.1 | 66.9 | 94.9 | 60.0 |
2020 | 91.5 | 95.2 | 78.8 | 99.7 | 105.1 | 68.6 | 73.3 | 100.5 | 71.9 |
2021 | 105.8 | 108.7 | 86.9 | 106.9 | 116.5 | 79.5 | 75.4 | 103.2 | 83.6 |
2022 | 110.8 | 121.8 | 99.2 | 108.7 | 125.1 | 84.8 | 80.6 | 110.4 | 97.3 |
2023 | 113.1 | 128.3 | 112.1 | 126.3 | 149.5 | 91.6 | 90.9 | 128.5 | 116.7 |
2024 | 116.2 | 131.4 | 127.0 | 140.2 | 172.1 | 98.5 | 94.9 | 146.8 | 120.6 |
2025 | 136.5 | 141.3 | 139.2 | 144.4 | 195.0 | 116.8 | 106.7 | 175.0 | 136.6 |
2026 | 152.4 | 149.2 | 157.0 | 149.4 | 208.5 | 133.9 | 116.8 | 189.2 | 152.5 |
2027 | 153.2 | 179.0 | 167.3 | 156.9 | 235.8 | 141.9 | 134.4 | 224.7 | 155.4 |
2028 | 177.3 | 211.1 | 199.4 | 180.3 | 269.5 | 142.6 | 144.3 | 225.3 | 180.8 |
2029 | 197.6 | 223.5 | 212.9 | 210.0 | 320.5 | 150.7 | 147.3 | 266.8 | 194.3 |
Global Adult Vaccines Market, Segmentation by Vaccine Type
The Global Adult Vaccines Market has been segmented by Vaccine Type into Monovalent and Multivalent. The complete Global Adult Vaccines Market segmentation by Vaccine Type can be seen below:
- Global Adult Vaccines Market, By Vaccine Type
- Monovalent
- Multivalent
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Vaccine Types mentioned above for historic (2019 - 2022) and forecast (2023 - 2029) periods with 2022 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Vaccine Type is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Adult Vaccines Market, by Vaccine Type (USD Million), 2019 - 2029
# | Monovalent | Multivalent |
---|---|---|
2019 | 101.3 | 90.0 |
2020 | 121.0 | 101.2 |
2021 | 133.7 | 112.3 |
2022 | 145.5 | 118.8 |
2023 | 161.5 | 123.2 |
2024 | 166.2 | 136.0 |
2025 | 190.7 | 137.1 |
2026 | 199.3 | 155.2 |
2027 | 211.5 | 179.3 |
2028 | 247.9 | 184.6 |
2029 | 258.5 | 203.4 |
Global Adult Vaccines Market, Segmentation by technology
The Global Adult Vaccines Market has been segmented by technology into Live Attenuated Vaccines, Inactivated Viral/Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines and Conjugate Vaccines. The complete Global Adult Vaccines Market segmentation by technology can be seen below:
- Global Adult Vaccines Market, By technology
- Live Attenuated Vaccines
- Inactivated Viral/Bacterial Vaccines
- Toxoid Vaccines
- Recombinant Vaccines
- Conjugate Vaccines
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the technologys mentioned above for historic (2019 - 2022) and forecast (2023 - 2029) periods with 2022 considered as the base year.
The report also provides an analysis of why the market size of the various segments by technology is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Adult Vaccines Market, by technology (USD Million), 2019 - 2029
# | Live Attenuated Vaccines | Inactivated Viral/Bacterial Vaccines | Toxoid Vaccines | Recombinant Vaccines | Conjugate Vaccines |
---|---|---|---|---|---|
2019 | 79.4 | 80.6 | 85.7 | 80.8 | 80.3 |
2020 | 93.2 | 91.5 | 93.1 | 96.7 | 83.5 |
2021 | 94.8 | 107.1 | 104.9 | 113.9 | 88.7 |
2022 | 96.9 | 116.0 | 114.0 | 128.8 | 94.1 |
2023 | 107.7 | 116.8 | 120.4 | 138.7 | 110.2 |
2024 | 109.7 | 137.8 | 125.5 | 145.1 | 127.7 |
2025 | 118.5 | 147.7 | 142.3 | 163.6 | 151.0 |
2026 | 141.8 | 163.6 | 168.4 | 195.6 | 173.0 |
2027 | 169.6 | 189.3 | 195.7 | 210.7 | 176.9 |
2028 | 190.7 | 193.7 | 214.0 | 247.1 | 208.1 |
2029 | 205.1 | 203.5 | 251.6 | 291.6 | 230.3 |
Global Adult Vaccines Market, Segmentation by End Use Industry
The Global Adult Vaccines Market has been segmented by End Use Industry into Hospitals, Clinics and Long Term Care Facilities. The complete Global Adult Vaccines Market segmentation by End Use Industry can be seen below:
- Global Adult Vaccines Market, By End Use Industry
- Hospitals
- Clinics
- Long Term Care Facilities
- Homecare
- Hospice
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the End Use Industrys mentioned above for historic (2019 - 2022) and forecast (2023 - 2029) periods with 2022 considered as the base year.
The report also provides an analysis of why the market size of the various segments by End Use Industry is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Adult Vaccines Market, by End Use Industry (USD Million), 2019 - 2029
# | Hospitals | Clinics | Long Term Care Facilities |
---|---|---|---|
2019 | 83.2 | 79.3 | 67.9 |
2020 | 94.8 | 86.1 | 69.7 |
2021 | 99.0 | 94.3 | 76.4 |
2022 | 106.4 | 109.5 | 89.9 |
2023 | 119.1 | 113.5 | 102.5 |
2024 | 123.7 | 129.4 | 116.2 |
2025 | 135.6 | 138.3 | 132.8 |
2026 | 140.2 | 143.9 | 150.6 |
2027 | 154.2 | 155.0 | 155.6 |
2028 | 175.1 | 178.7 | 174.9 |
2029 | 207.6 | 188.6 | 181.9 |
Global Adult Vaccines Market, Segmentation by Geography
In this report, the Global Adult Vaccines Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Adult Vaccines Market Share (%), by Geographical Region, 2022
North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
Find below the list of Countries covered in each of the aforementioned geographical regions:
North America - United States, Canada and Mexico
Latin America - Brazil, Argentina and Rest of Latin America
Europe - Germany, United Kingdom, France, Italy, Spain and Rest of Europe
Asia Pacific - Japan, China, India, Australia & New Zealand, South Korea, ASEAN (Association of South East Asian Nations) and Rest of Asia Pacific
Middle East & Africa - GCC Countries, Egypt, Israel, South Africa, Rest of Middle East & Africa
This report provides market size in USD Million and Year on Year (YOY) percentage growth analysis for the Adult Vaccines Market in all the Regions and Countries (specified above) for historic (2019 - 2022) and forecast (2023 - 2029) Periods with 2022 considered as the base year.
This report also provides an analysis of why the market size of Adult Vaccines in various regions and countries is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Market Dynamics
This report provides an in depth analysis of various factors that impact the dynamics of Global Adult Vaccines Market. These factors include; Market Drivers, Restraints and Opportunities Analysis, Market Opportunity Mapping, PEST (Political, Economic, Social and Technological) Analysis and Porter's Five Forces Analysis.
Drivers, Restraints and Opportunity Analysis
- The factors driving the growth of Global Adult Vaccines Market will be discussed in detail in the full report.
- The factors hindering the growth of Global Adult Vaccines Market will be discussed in detail in the full report.
- The new opportunities in Global Adult Vaccines Market will be discussed in detail in the full report.
- Global Adult Vaccines Market Drivers will be discussed in detail in the full report.
- Global Adult Vaccines Market Restraints will be discussed in detail in the full report.
- Global Adult Vaccines Market Opportunities will be discussed in detail in the full report.
Market Opportunity Map
This report provides market opportunity map for Adult Vaccines Market. The opportunity map (by market segments; Vaccine, Vaccine Type, technology and End Use Industry) is calculated based on current year market estimates, CAGR and collective revenue over the forecast period. Since, CAGR has been estimated considering all the factors impacting the market; starting from the company's presence, buyer behaviour, to government interference or support. The opportunity map inherently considers all the aforementioned factors impacting the market. The bubble size reflects the estimated opportunity for a particular segment or region, therefore, bigger the bubble size, larger the opportunity.
Global Adult Vaccines Market, Opportunity Map, By Region (2019 - 2029)
North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
PEST (Political, Economic, Social and Technological) Analysis
This report provides PEST analysis of Adult Vaccines Market. Various factors such as government interference in the market such as regulations (which include but are not limited to pricing and intellectual property policies) that might impact the market are analysed.
This report also provides an analysis of Economic factors affecting the market such as; purchasing power, which directly influences the market growth.
This report also provides an analysis of social factors such as social norms or cultural beliefs inhibiting or promoting the growth of the market
As part of PEST analysis, this report also provides analysis of the impact of Technological factors on growth or decline of a market.
- In depth analysis and insights about the impact of political factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of economic factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of social factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of technological factors on this market will be provided in the final report.
Porter's Five Force Analysis
This report provides Porter's Five Forces analysis of Global Adult Vaccines Market, which include; Bargaining Power of Suppliers, Bargaining Power of Buyers, Threat of New Entrants, Threat of Substitutes and Competitive Rivalry.
Bargaining Power of Suppliers:
Various factors such as; Supplier Switching Costs Relative to Firm Switching Costs, Supplier Competition and Possibility of Forward Integration, Presence of Substitute Inputs, Strength of Distribution Channels, and Supplier Concentration to Firm Concentration Ratio would be analysed to estimate bargaining power of suppliers in the Global Adult Vaccines Market. Bargaining power of suppliers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value. The global vaccine industry is expected to reach rapidly, led by the world's leading vaccine manufacturers who produce multiple kinds of vaccines.
Bargaining Power of Suppliers
Supplier Switching Costs Relative To Firm Switching Costs | Strength of Distribution Channels | Supplier Concentration to firm Concentration Ratio | Presence of Substitute Inputs | Supplier Competition and Possibly of Forward Integration |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
Bargaining Power of Buyers:
Various factors such as; Buyer Concentration to Firm Concentration Ratio, Buyer Switching Costs, Availability of Existing Substitute Products, Buyer Price Sensitivity, and Degree of Dependency upon Existing Channels of Distribution would be analysed to estimate bargaining power of buyers in the Global Adult Vaccines Market. Bargaining power of buyers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Bargaining Power of Buyers
Buyer Competition to Firm Concentration Ratio | Buyer Switching Costs | Availability of existing Substitute Products | Buyer Price Sensitivity | Degree of Dependency upon Existing Channels of Distribution |
---|---|---|---|---|
10 | 15 | 25 | 45 | 32 |
Threat of Substitutes:
Various factors such as; Availability of Substitutes, Number of Available Substitutes, Price of Substitute Products, Buyer Switching Costs, and Buyer Propensity to Substitute would be analysed to estimate threat of substitutes in the Global Adult Vaccines Market. Threat of substitutes will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of Substitutes:
Availability of Substitutes | Number of Available Substitutes | Price of Substitute Products | Buyer Switching Costs | Buyer Propensity to Substitute |
---|---|---|---|---|
20 | 35 | 10 | 2 | 5 |
Threat of New Entrants:
Various factors such as; Barriers to Entry, Economies of Scale, Product Differentiation, Customer Loyalty, Network Effect, and Access to Distribution Channels would be analysed to estimate threat of new entrants in the Global Adult Vaccines Market. Threat of new entrants will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of New Entrants:
Barriers to entry | Economics of scale | Product Differentiation | Customer Loyalty | Network Effect | Access to Ditribution Channels |
---|---|---|---|---|---|
2 | 35 | 25 | 10 | 15 | 55 |
Competitive Rivalry:
Various factors such as; Firm concentration Ratio, Level of Advertising Expense, Sustainable Competitive Advantage through Innovation, Competitive Strategy and Degree of Transparency would be analysed to estimate competitive rivalry in the Global Adult Vaccines Market. Competitive rivalry will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Industry Rivalry:
Firm Concentration Ratio | Level of Advertising Expense | Sustainable Competitive Adavantage through Innovation | Degree of Transparency | Competitive strategy |
---|---|---|---|---|
5 | 10 | 15 | 35 | 45 |
Competitive Landscape Analysis
Key players in Global Adult Vaccines Market include, GlaxoSmithKline Plcv, Merck & Co., Inc., Sanofi Pasteur, Pfizer, Inc., CSL Limited, Johnson & Johnson, Serum Institute of India, Medimmune and AstraZeneca Plc.
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
Company SWOT Analysis
This report also provides Heat map analysis of Products/Services Offered by different companies operating in this market.
Competitors Products/Services Heat Map Analysis
Company Vs. Product/Service | Company 1 | Company 2 | Company 3 | Company 4 | Company 5 | Company 6 | Company 7 | Company 8 | Company 9 | Company 10 |
---|---|---|---|---|---|---|---|---|---|---|
Product 1/Service 1 | ||||||||||
Product 2/Service 2 | ||||||||||
Product 3/Service 3 | ||||||||||
Product 4/Service 4 | ||||||||||
Product 5/Service 5 | ||||||||||
Product 6/Service 6 | ||||||||||
Product 7/Service 7 | ||||||||||
Product 8/Service 8 |
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Vaccine
- Market Snapshot, By Vaccine Type
- Market Snapshot, By technology
- Market Snapshot, By End Use Industry
- Market Snapshot, By Region
- Market Opportunity Map
- Global Adult Vaccines Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Restraints
- Opportunities
- Regulatory Scenario
- Pipeline Analysis/Technological Advancements
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bragaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Industry Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Adult Vaccines Market, By Vaccine, 2019 - 2029 (USD Million)
- Introduction
- Market Share Analysis, 2023 and 2029 (%)
- Y-o-Y Growth Analysis, 2020 - 2029
- Segment Trends
- Influenza
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2029 (USD Million)
- Tetanus, Diphtheria, Pertussis (Td/Tdap)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2029 (USD Million)
- Varicella
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2029 (USD Million)
- Human Papillomavirus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2029 (USD Million)
- Zoster
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2029 (USD Million)
- Measles, Mumps, Rubella (MMR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2029 (USD Million)
- Pneumococcal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2029 (USD Million)
- Hepatitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2029 (USD Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2029 (USD Million)
- Influenza
- Global Adult Vaccines Market, By Vaccine Type, 2019 - 2029 (USD Million)
- Introduction
- Market Share Analysis, 2023 and 2029 (%)
- Y-o-Y Growth Analysis, 2020 - 2029
- Segment Trends
- Monovalent
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2029 (USD Million)
- Multivalent
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2029 (USD Million)
- Monovalent
- Global Adult Vaccines Market, By technology, 2019 - 2029 (USD Million)
- Introduction
- Market Share Analysis, 2023 and 2029 (%)
- Y-o-Y Growth Analysis, 2020 - 2029
- Segment Trends
- Live Attenuated Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2029 (USD Million)
- Inactivated Viral/Bacterial Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2029 (USD Million)
- Toxoid Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2029 (USD Million)
- Recombinant Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2029 (USD Million)
- Conjugate Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2029 (USD Million)
- Live Attenuated Vaccines
- Global Adult Vaccines Market, By End Use Industry, 2019 - 2029 (USD Million)
- Introduction
- Market Share Analysis, 2023 and 2029 (%)
- Y-o-Y Growth Analysis, 2020 - 2029
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2029 (USD Million)
- Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2029 (USD Million)
- Long Term Care Facilities
- Introduction
- Market Share Analysis, 2023 and 2029 (%)
- Y-o-Y Growth Analysis, 2020 - 2029
- Segment Trends
- Homecare
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2029 (USD Million)
- Hospice
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2029 (USD Million)
- Homecare
- Hospitals
- Global Adult Vaccines Market, By Geography, 2019 - 2029 (USD Million)
- Introduction
- Market Share Analysis, 2023 and 2029 (%)
- Y-o-Y Growth Analysis, 2020 - 2029
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By technology, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use Industry, 2019 - 2029 (USD Million)
- United States
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By technology, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use Industry, 2019 - 2029 (USD Million)
- Canada
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By technology, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use Industry, 2019 - 2029 (USD Million)
- United States
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By technology, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use Industry, 2019 - 2029 (USD Million)
- Germany
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By technology, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use Industry, 2019 - 2029 (USD Million)
- United Kingdom
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By technology, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use Industry, 2019 - 2029 (USD Million)
- France
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By technology, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use Industry, 2019 - 2029 (USD Million)
- Italy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By technology, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use Industry, 2019 - 2029 (USD Million)
- Spain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By technology, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use Industry, 2019 - 2029 (USD Million)
- Rest of Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By technology, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use Industry, 2019 - 2029 (USD Million)
- Germany
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By technology, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use Industry, 2019 - 2029 (USD Million)
- Japan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By technology, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use Industry, 2019 - 2029 (USD Million)
- China
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By technology, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use Industry, 2019 - 2029 (USD Million)
- India
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By technology, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use Industry, 2019 - 2029 (USD Million)
- Australia & New Zealand
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By technology, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use Industry, 2019 - 2029 (USD Million)
- South Korea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By technology, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use Industry, 2019 - 2029 (USD Million)
- ASEAN (Association of South East Asian Countries)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By technology, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use Industry, 2019 - 2029 (USD Million)
- Rest of Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By technology, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use Industry, 2019 - 2029 (USD Million)
- Japan
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By technology, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use Industry, 2019 - 2029 (USD Million)
- GCC
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By technology, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use Industry, 2019 - 2029 (USD Million)
- Israel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By technology, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use Industry, 2019 - 2029 (USD Million)
- South Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By technology, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use Industry, 2019 - 2029 (USD Million)
- Rest of Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By technology, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use Industry, 2019 - 2029 (USD Million)
- GCC
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By technology, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use Industry, 2019 - 2029 (USD Million)
- Brazil
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By technology, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use Industry, 2019 - 2029 (USD Million)
- Mexico
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By technology, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use Industry, 2019 - 2029 (USD Million)
- Argentina
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By technology, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use Industry, 2019 - 2029 (USD Million)
- Rest of Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By technology, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End Use Industry, 2019 - 2029 (USD Million)
- Brazil
- North America
- Global Adult Vaccines Market, By Vaccine, 2019 - 2029 (USD Million)
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- GlaxoSmithKline Plcv
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Merck & Co., Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Sanofi Pasteur
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Pfizer, Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- CSL Limited
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Johnson & Johnson
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Serum Institute of India
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Medimmune
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- AstraZeneca Plc
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- GlaxoSmithKline Plcv
- Analyst Views
- Future Outlook of the Market
ReAnIn's Most Viewed Titles:
In the year 2022, the Global Advanced Visualization Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2029, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2022, the Global Aesthetic Laser Devices Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2029, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2022, the Global Aesthetic Fillers Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2029, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2022, the Global Aesthetic Medicine Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2029, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%